Evaluation of orally administered robenacoxib versus ketoprofen for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats.

Objective: To evaluate the efficacy and tolerability of oral administration of robenacoxib for treatment of acute pain and inflammation associated with musculoskeletal disorders in cats.

Animals: 155 cats requiring relief of signs of pain and inflammation associated with acute musculoskeletal disorders.

Procedures: The study was a multicenter, prospective, randomized, masked, noninferiority field trial.